Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 432T3 | — |
Expired Dose Administered; This non-serious case was reported by the other health professional via call center representative and described the occurrence of expired vaccine used in a 63-year-old female patient who received Herpes zoster (Shingrix) (batch number 432T3, expiry date 18-AUG-2024) for prophylaxis. On 17-JUL-2025, the patient received Shingrix. On 17-JUL-2025, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: Expired Dose Administered). The outcome of the expired vaccine used was not applicable. Linked case(s) involving the same patient: US2023AMR123970 Additional Information: GSK Receipt Date: 28-JUL-2025 There was administration of an expired dose of Shingrix which led to expired vaccine used Consented to follow up.